These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29960985)

  • 1. Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial.
    Thomas MC; Woodward M; Li Q; Pickering R; Tikellis C; Poulter N; Cooper ME; Marre M; Zoungas S; Chalmers J;
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29960985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated urinary levels of 8-oxo-2'-deoxyguanosine, (5'R)- and (5'S)-8,5'-cyclo-2'-deoxyadenosines, and 8-iso-prostaglandin F
    Kant M; Akış M; Çalan M; Arkan T; Bayraktar F; Dizdaroglu M; İşlekel H
    DNA Repair (Amst); 2016 Dec; 48():1-7. PubMed ID: 27769710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial 8-hydroxy-2'-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus.
    Wang XB; Cui NH; Liu X; Liu X
    Cardiovasc Diabetol; 2020 Feb; 19(1):22. PubMed ID: 32075646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus.
    Alshehry ZH; Mundra PA; Barlow CK; Mellett NA; Wong G; McConville MJ; Simes J; Tonkin AM; Sullivan DR; Barnes EH; Nestel PJ; Kingwell BA; Marre M; Neal B; Poulter NR; Rodgers A; Williams B; Zoungas S; Hillis GS; Chalmers J; Woodward M; Meikle PJ
    Circulation; 2016 Nov; 134(21):1637-1650. PubMed ID: 27756783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial.
    Kumar A; Patel DR; Wolski KE; Lincoff AM; Kashyap SR; Ruotolo G; McErlean E; Weerakkody G; Riesmeyer JS; Nicholls SJ; Nissen SE; Menon V
    Diab Vasc Dis Res; 2019 Mar; 16(2):171-177. PubMed ID: 31014095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus.
    Fu L; Zhou Y; Sun J; Zhu Z; Xing Z; Zhou S; Wang Y; Tai S
    Cardiovasc Diabetol; 2021 Oct; 20(1):201. PubMed ID: 34610830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial.
    Blomster JI; Woodward M; Zoungas S; Hillis GS; Harrap S; Neal B; Poulter N; Mancia G; Chalmers J; Huxley R
    BMJ Open; 2016 Jan; 6(1):e009668. PubMed ID: 26747037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative DNA damage in diabetes mellitus: its association with diabetic complications.
    Hinokio Y; Suzuki S; Hirai M; Chiba M; Hirai A; Toyota T
    Diabetologia; 1999 Aug; 42(8):995-8. PubMed ID: 10491760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine (8-oxodG) and 8-Hydroxy-2'-Deoxyguanosine (8-OHdG) as a Potential Biomarker for Gestational Diabetes Mellitus (GDM) Development.
    Urbaniak SK; Boguszewska K; Szewczuk M; Kaźmierczak-Barańska J; Karwowski BT
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31947819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
    Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
    Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study.
    Harris K; Oshima M; Sattar N; Würtz P; Jun M; Welsh P; Hamet P; Harrap S; Poulter N; Chalmers J; Woodward M
    Diabetologia; 2020 Aug; 63(8):1637-1647. PubMed ID: 32385604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear oxidative damage correlates with poor survival in colorectal cancer.
    Sheridan J; Wang LM; Tosetto M; Sheahan K; Hyland J; Fennelly D; O'Donoghue D; Mulcahy H; O'Sullivan J
    Br J Cancer; 2009 Jan; 100(2):381-8. PubMed ID: 19066606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Concentrations of Redox Biomarkers Do Not Improve the Prediction of Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus.
    Cournot M; Burillo E; Saulnier PJ; Planesse C; Gand E; Rehman M; Ragot S; Rondeau P; Catan A; Gonthier MP; Feigerlova E; Meilhac O; Hadjadj S
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study.
    Mantovani A; Busti F; Borella N; Scoccia E; Pecoraro B; Sani E; Morandin R; Csermely A; Piasentin D; Grespan E; Castagna A; Bilson J; Byrne CD; Valenti L; Girelli D; Targher G
    Cardiovasc Diabetol; 2024 Aug; 23(1):305. PubMed ID: 39154180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative meta-analysis of peripheral 8-hydroxy-2'-deoxyguanosine (8-OHdG) or 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG) levels across mood episodes in bipolar disorder.
    Çeli K HEA; Tuna G; Ceylan D; Küçükgöncü S
    Psychoneuroendocrinology; 2023 May; 151():106078. PubMed ID: 36931055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial.
    Batty GD; Li Q; Czernichow S; Neal B; Zoungas S; Huxley R; Patel A; de Galan BE; Woodward M; Hamet P; Harrap SB; Poulter N; Chalmers J;
    J Am Coll Cardiol; 2010 Nov; 56(23):1908-13. PubMed ID: 21109113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus.
    Xing Z; Peng Z; Wang X; Zhu Z; Pei J; Hu X; Chai X
    Cardiovasc Diabetol; 2020 Mar; 19(1):39. PubMed ID: 32213183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes.
    Hillis GS; Welsh P; Chalmers J; Perkovic V; Chow CK; Li Q; Jun M; Neal B; Zoungas S; Poulter N; Mancia G; Williams B; Sattar N; Woodward M
    Diabetes Care; 2014; 37(1):295-303. PubMed ID: 24089534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques.
    Martinet W; Knaapen MW; De Meyer GR; Herman AG; Kockx MM
    Circulation; 2002 Aug; 106(8):927-32. PubMed ID: 12186795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between glucose excursion and the activation of oxidative stress in patients with newly diagnosed type 2 diabetes or impaired glucose regulation.
    Zheng F; Lu W; Jia C; Li H; Wang Z; Jia W
    Endocrine; 2010 Feb; 37(1):201-8. PubMed ID: 20963571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.